Pharmacological Treatment of Chronic Congestive Heart Failure

Author:

Poskurica Mina12,Stevanović Đorđe23,Poskurica Mileta1,Petrović Marina34

Affiliation:

1. University of Kragujevac , Faculty of Medical Sciences , Serbia

2. Cardiology Clinic, Clinical Center Kragujevac , Serbia

3. University of Kragujevac , Faculty of Medical Sciences, Department of Internal medicine , Serbia

4. Pulmology Clinic, Clinical Center Kragujevac , Serbia

Abstract

Abstract Chronic congestive heart failure is a clinical syndrome based on the progressive deterioration of contractile (systolic) heart function due to structural or functional disorders. The incidence of the disease increases with age, so the prevalence in people older than 75 years is greater than 10%. Due to the different clinical presentation, the pharmacological approach to the patient is individual, and most patients are treated on an outpatient basis, according to the guidelines taken from the recommendations of professional associations. Hospitalization is necessary in severe forms of CHF or acute exacerbations. Patients with severe hemodynamic disturbances due to acute CHF require treatment in intensive care units, due to specific cardiovascular therapy, respiratory support and vital functions monitoring. Individualized, stepwise and rational pharmacological therapy achieves significant symptomatic and functional improvement in most patients.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference29 articles.

1. 1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). European Heart Journal, Volume 37, Issue 27, 14 July 2016, Pages 2129–2200, https://doi.org/10.1093/eurheartj/ehw128.10.1093/eurheartj/ehw12827206819

2. 2. Поскурица М, Петровић Д. Застојна срчана инсуфицијенција код болесника са оштећеном функцијом бубрега. Srp Arh Celok Lek. 2014 Nov-Dec;142(11-12):747-755 DOI: 10.2298/SARH1412747P; UDC: 616.12-008.6; 616.61-78.

3. 3. Januzzi LJ, Jr., Mann LD. Clinical Assessment of Heart Failure. In. Douglas LM, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s Heart Disease a Textbook of Cardiovascular Medicine, 10th ed., Elsevier-Saunders co. Philadelphia, 2015; Chapt 23: 473 – 483. ISBN: 978-1-4557-5134-1.

4. 4. Hanna BE. Practical Cardiovaskular Medicine, 2017; Willey Blackwell, Part 2.: 93-141; ICBN: 9781119233497.

5. 5. Felker MG, Ellison HD, Mullens W, Cox LZ, Testani. MJ. Diuretic Therapy for Patients With Heart Failure. J Am Coll Cardiol. 2020 Mar, 75 (10) 1178–1195. doi: 10.1016/j.jacc.2019.12.059.10.1016/j.jacc.2019.12.05932164892

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3